SLE patients with low complement C3 levels (<85 mg/dl) showed a higher percentage of CD19+PLT+ and a tendency to higher percentages of CD4+PLT+ and CD8+PLT+ than those with normal levels (85-193 mg/dl) (Figure 5(c)). The gene discussed is CD19; the disease is systemic lupus erythematosus.